Virtus LifeSci Biotech Products ETF Rating $103.80 0.00 (0.00%) Closing price 09/18/2026 04:10 PM EasternExtended Trading$104.89 +1.09 (+1.05%) As of 05:38 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsNews and TrendsOwnershipRatingsShort Interest Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.62Holdings in BBP have an aggregate rating of Moderate Buy based on 350 analyst ratings issued in the past year covering 25 companies (47.1% of the portfolio).BBP Aggregate Price Target$103.80High Prediction$103.80Average Prediction$103.80Low Prediction$103.80Holdings in BBP have an aggregate price target of $103.80 and a range of $103.80 to $103.80 covering 25 companies (47.1% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBP Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.59%MRNAModerna$154.030.0%1.9985 of 5 stars2.08$76.72 -50.2%24Trending NewsGap Up2.67%OMEROmeros$17.873.9747 of 5 stars2.67$38.00 112.6%6Positive News2.65%IOVAIovance Biotherapeutics$10.251.5604 of 5 stars2.45$9.11 -11.1%112.46%VSTMVerastem$7.442.8911 of 5 stars2.82$13.83 85.9%11Analyst DowngradeHigh Trading Volume1.96%PGENPrecigen$7.784.2054 of 5 stars2.80$14.50 86.4%5Gap UpHigh Trading Volume1.95%HALOHalozyme Therapeutics$112.452.9124 of 5 stars2.62$91.20 -18.9%13Trending NewsGap DownHigh Trading Volume1.89%ZLABZai Lab$25.701.8955 of 5 stars2.71$37.25 44.9%7Gap Up1.85%KNSAKiniksa Pharmaceuticals International$77.17-0.1%4.1322 of 5 stars2.80$87.38 13.2%10Positive NewsHigh Trading Volume1.82%RIGLRigel Pharmaceuticals$46.644.5559 of 5 stars2.57$59.00 26.5%7Positive NewsHigh Trading Volume1.81%SRPTSarepta Therapeutics$20.113.6354 of 5 stars2.15$25.69 27.7%201.80%TARSTarsus Pharmaceuticals$78.093.1046 of 5 stars2.80$94.00 20.4%101.80%KURAKura Oncology$11.733.3956 of 5 stars2.75$25.40 116.5%121.70%NUVBNuvation Bio$5.84-0.3%2.9242 of 5 stars2.69$13.00 122.8%13Gap Up1.68%GERNGeron$1.301.3765 of 5 stars2.20$4.00 207.7%51.67%ONCBeOne Medicines$350.843.0493 of 5 stars3.00$402.71 14.8%171.66%REGNRegeneron Pharmaceuticals$784.853.6319 of 5 stars2.58$802.18 2.2%24Analyst UpgradeHigh Trading Volume1.63%PTGXProtagonist Therapeutics$143.001.8871 of 5 stars2.89$147.13 2.9%18Positive NewsHigh Trading Volume1.63%ACADACADIA Pharmaceuticals$27.294.4025 of 5 stars2.78$34.36 25.9%18Positive NewsHigh Trading Volume1.59%INSMInsmed$120.003.0541 of 5 stars3.00$204.91 70.8%25Gap Up1.57%ZYMEZymeworks$26.572.7276 of 5 stars2.75$41.00 54.3%12Gap Up1.55%XERSXeris Biopharma$8.204.1226 of 5 stars2.43$12.80 56.1%7Analyst UpgradeHigh Trading Volume1.54%IMCRImmunocore$32.003.6046 of 5 stars2.58$56.38 76.2%121.54%TVTXTravere Therapeutics$62.761.5905 of 5 stars2.75$68.00 8.3%12Trending NewsGap Up1.53%ASNDAscendis Pharma A/S$236.724.6544 of 5 stars3.00$310.75 31.3%21High Trading Volume1.51%AMGNAmgen$385.653.3776 of 5 stars2.33$381.32 -1.1%30Trending NewsHigh Trading Volume This page (NYSEARCA:BBP) was last updated on 9/21/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
